Human Granzyme A Platinum ELISA

Also known as: Hanukkah factor, Granzyme 1, CTLA 3, CTL tryptase

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS2026*

Cat. No. Size
BMS2026 96 tests
BMS2026TEN 10 x 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human Granzyme A Platinum ELISA.

Click on image to view more information.

  • Data for Human Granzyme A Platinum ELISA.
Description

Description: The human Granzyme A ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human Granzyme A. The human Granzyme A ELISA is for research use only. Not for diagnostic or therapeutic procedures.

Granzymes are exogenous serine proteinases that are released from cytoplasmic granules of cytotoxic lymphocytes (CTLs) and NK cells. The name 'granzymes' is derived from: granules + enzymes. These granules contain next to granzymes other proteins including a poreforming protein (Perforin). Upon binding of the CTL to a target cell (by CTL-receptor and antigen-presenting MHC molecules on the target cell) the contents of the granules are released in the intercellular space where after perforine will perforate the target cell membrane by forming transmembrane pores. Through these pores the granzymes can now enter the cytosol of the target cell. Granzyme B activates the intracellular cascade of caspases finally resulting in the killing of the target cells.

Percentages of the Granzyme A and B positive CTLs can be determined by flow cytometry and immunocytochemical methods for many disorders.

Not all granzymes enter the target cell, part of them also 'leak' in to the peripheral blood and other biological fluids. Detectable amounts of granzymes have been found to circulate in healthy volunteers. These soluble granzymes can be measured by ELISAs. Increased levels of soluble granzymes have been found with patients suspected of an increased NK cell and CTL-response caused by systemic viral infections such as EBV, HIV, CMV, hepatitis A and Dengue fever. Soluble Granzyme A and B is increased in synovial fluid from rheumatoid arthritis and significantly higher than levels in patients with osteoarthrosis. Granzymes are likely involved in the acute rejection of kidney-transplants, as infiltrating lymphocytes in the rejected kidney strongly express granzymes. Increasing plasma levels of soluble granzymes in patients with a kidney transplants.

Details
Reactivity Human
Sample Volume 50 uL
Suitable Sample Types cell culture supernatant, serum, plasma
Sensitivity 0.4 pg/mL
Standard Curve Range 0.8 - 600 pg/mL
Components Aluminium pouch(es) with a Microwell Plate coated with monoclonal antibody to human Granzyme A
Biotin-Conjugate anti-human Granzyme A monoclonal antibody
Streptavidin-HRP
Human Granzyme A Standard Concentrate, 600 pg/ml upon dilution
Wash Buffer Concentrate 20x (PBS with 1% Tween 20)
Dilution Buffer Concentrate 5x
Substrate Solution (tetramethyl-benzidine)
Stop Solution (1M Phosphoric acid)
Blue-Dye
Green-Dye
Red-Dye
Adhesive Films
Reported Applications ELISA
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
13-5785 Anti-Human/Mouse Notch1 Biotin FC RUO
88-6611 Apo-Direct Apoptosis Detection FC, ICC RUO
88-8005 Annexin V Apoptosis Detection Kit FITC FC RUO
88-7004 CaspGLOW™ Fluorescein Active Caspase-3 Staining Kit FC, ICC RUO
BMS2027* Human Granzyme B Platinum ELISA ELISA RUO
References

References: Spaeny-Dekking,E.H.; Hanna,W.L.; Wolbink,A.M.; Wever,P.C.; Kummer,J.A.; Swaak,A.J.; Middeldorp,J.M.; Huisman,H.G.; Froelich,C.J.; Hack,C.E.. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J.Immunol. 1998;160:3610-3616. (Link)


View More Products

AntigensArea of BiologyCell TypeFormats